Gene Biotherapeutics Inc (CRXM)
0.00
USD |
OTCM |
May 24, 16:00
Gene Biotherapeutics Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
December 31, 2012 | 0.00 |
September 30, 2012 | 0.00 |
June 30, 2012 | 0.00 |
March 31, 2012 | 0.00 |
December 31, 2011 | 0.00 |
September 30, 2011 | 0.00 |
June 30, 2011 | 0.00 |
March 31, 2011 | 0.00 |
December 31, 2010 | 0.00 |
September 30, 2010 | 0.00 |
June 30, 2010 | 0.00 |
March 31, 2010 | 0.00 |
December 31, 2009 | 0.00 |
September 30, 2009 | -0.2065 |
June 30, 2009 | -0.3167 |
March 31, 2009 | -0.3879 |
December 31, 2008 | -5.348 |
September 30, 2008 | 0.00 |
June 30, 2008 | 0.7519 |
March 31, 2008 | 0.6086 |
December 31, 2007 | 0.5605 |
September 30, 2007 | 0.00 |
Date | Value |
---|---|
June 30, 2007 | 0.00 |
March 31, 2007 | 0.00 |
December 31, 2006 | 0.00 |
September 30, 2006 | 0.00 |
June 30, 2006 | 0.00 |
March 31, 2006 | 0.00 |
September 30, 2005 | 0.00 |
June 30, 2005 | 0.00 |
March 31, 2005 | 0.00 |
December 31, 2004 | 0.00 |
September 30, 2004 | 0.00 |
June 30, 2004 | 0.00 |
March 31, 2004 | 0.00 |
December 31, 2003 | 0.00 |
September 30, 2003 | 0.00 |
June 30, 2003 | 0.00 |
March 31, 2003 | 0.00 |
December 31, 2002 | 0.00 |
September 30, 2002 | 0.00 |
June 30, 2002 | -1.260 |
March 31, 2002 | -2.049 |
December 31, 2001 | -4.799 |
September 30, 2001 | 0.00 |
June 30, 2001 | 0.00 |
March 31, 2001 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
AIM ImmunoTech Inc | 0.5332 |
Perspective Therapeutics Inc | -- |
Protalix BioTherapeutics Inc | 0.6856 |
Electromed Inc | 0.00 |
Armata Pharmaceuticals Inc | -- |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 0.3739M |
Total Liabilities (Quarterly) | 4.092M |
Shareholders Equity (Quarterly) | -3.718M |